This audit examines the effectiveness of the Australian Nuclear Science and Technology Organisation’s management of assets involved in the manufacture, production and distribution of nuclear medicines.

Genomics, where all a person’s genes are examined, as well as the interactions of those genes with each other, is proving a powerful tool for medicine. This report explores some of the challenges currently facing this rapidly evolving sector.

From vaccines to antibiotics, health and medical research has improved, extended, and saved lives. In this episode, Torrens University researchers talk about the need to build a new GP model of care for Australia’s rapidly ageing population.

This report examines the opportunities to deliver better health care for Australians through our regulatory and health technology assessment process for both medicines and technologies.

For the 2 million Australians living with rare diseases, access to medicines can be inadequate. This report reassesses 2014 research by the McKell Institute, assessing the state of rare disease therapies in Australia.